REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 113 filers reported holding REVANCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $960,590 | -65.1% | 83,748 | -23.1% | 0.16% | -59.2% |
Q2 2023 | $2,755,247 | -21.2% | 108,860 | +0.2% | 0.38% | -24.2% |
Q1 2023 | $3,498,425 | +278881.3% | 108,613 | +59.9% | 0.51% | +160.5% |
Q4 2022 | $1,254 | -99.9% | 67,933 | -1.0% | 0.20% | -34.1% |
Q3 2022 | $1,853,000 | +110.8% | 68,622 | +7.9% | 0.30% | +108.5% |
Q2 2022 | $879,000 | -30.1% | 63,588 | -1.4% | 0.14% | -9.6% |
Q1 2022 | $1,258,000 | -40.4% | 64,509 | -50.1% | 0.16% | -35.1% |
Q4 2021 | $2,112,000 | -42.3% | 129,384 | -1.5% | 0.24% | -46.1% |
Q3 2021 | $3,659,000 | -6.0% | 131,325 | 0.0% | 0.45% | -0.9% |
Q2 2021 | $3,892,000 | +0.2% | 131,325 | -5.5% | 0.45% | -4.4% |
Q1 2021 | $3,885,000 | +78.8% | 138,989 | +81.3% | 0.47% | +75.6% |
Q4 2020 | $2,173,000 | -13.6% | 76,671 | -23.3% | 0.27% | -25.0% |
Q3 2020 | $2,514,000 | +53.4% | 100,000 | +49.0% | 0.36% | +33.8% |
Q2 2020 | $1,639,000 | +10.7% | 67,102 | -32.9% | 0.27% | -10.3% |
Q1 2020 | $1,480,000 | -31.8% | 100,000 | +14.5% | 0.30% | +17.6% |
Q3 2018 | $2,171,000 | -9.5% | 87,355 | 0.0% | 0.26% | -15.0% |
Q2 2018 | $2,398,000 | -30.1% | 87,355 | -21.6% | 0.30% | -33.5% |
Q1 2018 | $3,430,000 | -19.4% | 111,360 | -6.4% | 0.45% | -19.6% |
Q4 2017 | $4,253,000 | +47.1% | 118,952 | +13.4% | 0.56% | +42.7% |
Q3 2017 | $2,891,000 | -12.3% | 104,928 | -16.0% | 0.39% | -16.7% |
Q2 2017 | $3,298,000 | +60.6% | 124,932 | +26.6% | 0.47% | +46.6% |
Q1 2017 | $2,053,000 | +8.7% | 98,684 | +8.2% | 0.32% | +3.5% |
Q4 2016 | $1,888,000 | +35.4% | 91,228 | +6.1% | 0.31% | +38.2% |
Q3 2016 | $1,394,000 | +25.5% | 86,000 | +5.3% | 0.22% | +21.6% |
Q2 2016 | $1,111,000 | -22.1% | 81,701 | 0.0% | 0.18% | -24.2% |
Q1 2016 | $1,426,000 | -41.8% | 81,701 | +13.9% | 0.24% | -36.3% |
Q4 2015 | $2,449,000 | +14.8% | 71,701 | 0.0% | 0.38% | +9.4% |
Q3 2015 | $2,134,000 | -6.9% | 71,701 | 0.0% | 0.35% | +1.2% |
Q2 2015 | $2,293,000 | – | 71,701 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |